Indiscriminate use of Convalescent Plasma therapy not advisable for Covid-19 treatment: ICMR

Indiscriminate use of Convalescent Plasma therapy not
advisable for Covid-19 treatment: ICMR

Indian Council of Medical Research (ICMR) has advised that indiscriminate use of Convalescent Plasma therapy is not advisable for the treatment of the Covid-19 cases. ICMR conducted an open label phase II multicentre randomised controlled trial in India across 39 public and private hospitals on use of convalescent plasma in the management of cases with …

Indiscriminate use of Convalescent Plasma therapy not
advisable for Covid-19 treatment: ICMR
Read More »